Market Overview

UPDATE: Jefferies Upgrades Sabra Health Care REIT on Attractive Entry Point

Related SBRA
Benzinga's Top Initiations
Wells Fargo Initiates Sabra Healthcare At Market Perform
REIT rally running out of steam? (Seeking Alpha)

In a report published Wednesday, Jefferies analyst Omotayo Okusanya upgraded the rating on Sabra Health Care REIT (NASDAQ: SBRA) from Hold to Buy, but lowered the price target from $27.00 to $26.00.

In the report, Jefferies noted, “We had previously downgraded SBRA stock from Buy to Hold back in April on concerns of valuation following a 250% run-up in the stock since 2011. However, with the stock now down over 26% since May, shares appear oversold, offering an attractive entry point. While a rising cost of capital and recent lack of deal flow are concerns, recent pipeline agreements suggest new transactions are imminent. Upgrade to Buy but lower PT to $26.”

Sabra Health Care REIT closed on Tuesday at $22.49.

Latest Ratings for SBRA

Jan 2015JMP SecuritiesDowngradesMarket PerformMarket Underperform
Jan 2015JefferiesMaintainsHold
Jan 2015BarclaysMaintainsOverweight

View More Analyst Ratings for SBRA
View the Latest Analyst Ratings

Posted-In: Jefferies Omotayo OkusanyaAnalyst Color Upgrades Analyst Ratings


Related Articles (SBRA)

Around the Web, We're Loving...

Get Benzinga's Newsletters